Which description best characterizes study endpoints?

Which description best characterizes study endpoints?

• A. They are random measurements unrelated to PK/PD.
• B. They are only measures of safety.
• C. They are response variables chosen to assess drug effects related to PK, PD, efficacy, and safety.
• D. They are not defined prospectively.

Answer: (C)

Endpoints are the outcomes a clinical trial is designed to measure to determine whether the drug has the intended effect. They are predefined in the study protocol and include variables that reflect how the drug behaves (PK), how it affects the body (PD), as well as efficacy and safety outcomes. Because they are chosen in advance as the response variables, endpoints provide a focused way to assess the drug’s impact and to interpret the results without bias. The correct description captures that endpoints are planned measures tied to the drug’s effects across PK/PD, efficacy, and safety, rather than random or unrelated measurements. They are not limited to safety alone, and they are defined prospectively to guide data collection and analysis.

Endpoints are the outcomes a clinical trial is designed to measure to determine whether the drug has the intended effect. They are predefined in the study protocol and include variables that reflect how the drug behaves (PK), how it affects the body (PD), as well as efficacy and safety outcomes. Because they are chosen in advance as the response variables, endpoints provide a focused way to assess the drug’s impact and to interpret the results without bias.

The correct description captures that endpoints are planned measures tied to the drug’s effects across PK/PD, efficacy, and safety, rather than random or unrelated measurements. They are not limited to safety alone, and they are defined prospectively to guide data collection and analysis.